Stockscreener 앱 받기
1.56
8.77%
-0.15
시간 외 거래:
1.57
0.01
+0.64%
전일 마감가:
$1.71
열려 있는:
$1.68
하루 거래량:
38,168
Relative Volume:
1.46
시가총액:
$16.83M
수익:
$1.08M
순이익/손실:
$-26.95M
주가수익비율:
-0.5433
EPS:
-2.8712
순현금흐름:
$-21.69M
1주 성능:
-2.50%
1개월 성능:
-12.36%
6개월 성능:
-57.49%
1년 성능:
-72.54%
1일 변동 폭
$1.5499
$1.71
1주일 범위
$1.5499
$1.84
52주 변동 폭
$1.45
$5.49
Pluri Inc Stock (PLUR) Company Profile
명칭
Pluri Inc
전화
972-74-710-7171
주소
MATAM ADVANCED TECHNOLOGY PARK, HAIFA
Compare PLUR vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLUR
Pluri Inc
|
1.56 | 19.10M | 1.08M | -26.95M | -21.69M | -2.8712 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Pluri Inc 주식(PLUR)의 최신 뉴스
Pluri (PLUR) Results at a Glance: The EPS Result Is Below Expectation; Trading Response: Shares Finish 0.57% UpQuarterly Earnings Report - vinanet.vn
Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment - Sahm
symbol__ Stock Quote Price and Forecast - CNN
Pluri Subsidiary to Acquire Fishway BV, Diluting Pluri Stake to 58% - Minichart
Pluri Subsidiary Acquires Fishway to Expand Cultivated Seafood - TipRanks
Pluri Inc. (PLUR) Holds at $1.75 as Traders Eye Key Support and ResistanceBull Pennant - Vinanet
PLUR Q2 2026 Earnings: Wider-Than-Expected Loss Reflects Continued Investment in Cell Therapy PipelineLong-Term Guidance - vinanet.vn
Pluri Inc. Revenue Breakdown – NASDAQ:PLUR - TradingView
Pluri Inc (PLUR) Stock News Today - TradingKey
Pluri Inc (PLUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PLUR Q2 2026 Earnings: Wider-than-Expected Loss Reflects Clinical-Stage InvestmentGross Profit Margin - vinanet.vn
PLUR Q2 2026 Earnings: Wider-than-Expected Loss Highlights Pre-Revenue Investment CostsManagement Guidance Update - vinanet.vn
Pluri Inc (PLUR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cellav Health and Aesthetics Ltd Completes Regulatory Registration of Regenativo+ in the UK - marketscreener.com
Pluri's subsidiary Cellav completes UK regulato... - Pluang
Pluri subsidiary completes UK regulatory registration for aesthetics product - Investing.com
Pluri’s Regenativo+ Is Registered for Sale in a $900M UK Market - Stock Titan
Pluri Inc (PLUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Pluri Inc. (PLUR) Gains Slightly as Stock Tests Key Resistance Near $1.76Fair Value Gap - dars.gov.et
Pluri Inc (PLUR) Balance Sheet - TradingKey
PLUR|Pluri Inc|Price:1.550|Chg%:-0.010 - TradingKey
Pluri Inc (PLUR) Cash Flow - TradingKey
Pluri Inc (PLUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PLUR|Pluri Inc|Price:1.640| - TradingKey
Pluri Inc (PLUR) Earnings Date & Reports & Earnings News - TradingKey
Pluri Inc (PLUR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Pluri Inc (PLUR) Institutional Confidence - TradingKey
PLUR|Pluri Inc|Price:1.780|Chg%:-0.040 - TradingKey
Pluri Inc. Q2 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues R&D InvestmentsBanking Earnings Report - dars.gov.et
Pluri Inc (PLUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pluri Inc (PLUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Enterprise value to revenue forward of Pluri Inc. – NASDAQ:PLUR - TradingView
Enterprise value to revenue forward of Pluri Inc. – FWB:4DX - TradingView
PLUR Q2 2026 Earnings: EPS Misses Estimates, Stock Declines Amid Revenue Absence - vinanet.vn
Plurilock Security Inc.'S Aurora Subsidiary Announces Selection as SEWP VI Awardee Enabling U.S. Federal Agencies to Procure It and Cybersecurity Solutions - marketscreener.com
PLUR Q2 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Widens LossEarnings Growth Analysis - vinanet.vn
PLUR Q2 2026 Earnings: EPS Misses Estimates Amid Ongoing R&D Investments; Stock Rises 3.3%Strong Earnings Momentum - Vinanet
Pluri Inc. (PLUR) Rallies 3.33% from Support: Key Levels to WatchReversal Setup Alerts - dars.gov.et
Price to book forward of Pluri Inc. – LS:A408KW - TradingView
Pluri in ongoing talks to extend EIB financing - The Globe and Mail
Pluri Inc. Files 8-K: Company Updates, NASDAQ Listing, and EIB Loan Discussions – July 2026 - Minichart
Pluri chairman raises stake above 30%; shares up - MSN
Pluri's Chairman Increases Investment and Ownership Stake (PLUR) - GuruFocus
Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30% - marketscreener.com
Pluri Chairman Builds 30%-Plus Position With $17M Investment - Stock Titan
Pluri Receives Nasdaq Non-Compliance Notice, Faces Delisting Risk - TipRanks
Pluri Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Pluri Inc. Q2 2026 Earnings: EPS Miss Reflects Ongoing R&D InvestmentOne-Time Gain Impact - dars.gov.et
Pluri Inc. (PLUR) Q2 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues R&D Investment - dars.gov.et
Pluri (PLUR) director Doron Shorrer files Form 3 listing share holdings - Stock Titan
PLURPluri Inc Latest SEC Filings - Finviz
Pluri Inc (PLUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
3.22%
자본화:
|
볼륨(24시간):